Linked Life Data

8867272

Source:http://linkedlifedata.com/resource/pubmed/id/8867272

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1996-11-22
pubmed:abstractText
Treating ischemic stroke we could compare a (control-)group of 318 patients under up to date hemodilution therapy to a group of 100 patients receiving exactly the same treating scheme but including an add-on administering of Cerebrolysin. It proved a statistically validated better outcome within the Cerebrolysin add-on treated group evaluated by the Barolin-Neuro-Rehabilitation Scale. 1) More effect on social and occupational parameters than on motor functions, but also including some of those. 2) Cerebrolysin accelerates recovery and therewith offers better starting points for rehabilitation. As stroke is one of the main social-medical neuro-rehabilitation and gerontological problems of our days these results should be recognized in a general therapeutical use.
pubmed:language
ger
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0043-5341
pubmed:author
pubmed:issnType
Print
pubmed:volume
146
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
41-8
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
1996
pubmed:articleTitle
[Hemodilution therapy with neuron metabolism specific therapy in ischemic stroke--encouraging results of a comparative study].
pubmed:affiliation
Aus der Neurologischen Abteilung, Ludwig-Boltzmann-Institut für Neuro-Rehabilitation und -Prophylaxe.
pubmed:publicationType
Journal Article, Comparative Study, English Abstract